cytomegalovirus pp65-specific cytotoxic T lymphocytes
Sponsors
University of Louisville, Milton S. Hershey Medical Center
Conditions
Cancer
Phase 1
Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy
CompletedNCT00509691
Start: 2007-06-30End: 2011-12-31Updated: 2017-05-09
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
NCT00769613
Start: 2008-08-31Target: 20Updated: 2013-12-18